MGX – metagenomi, inc. (US:NASDAQ)
Stock Stats
News
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference [Yahoo! Finance]
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Metagenomi to Present at Jefferies Global Healthcare Conference in London
Form 4 Metagenomi, Inc. For: Sep 05 Filed by: Thomas Brian C.
Form 4 Metagenomi, Inc. For: Sep 05 Filed by: Wapnick Pamela
Form 4 Metagenomi, Inc. For: Sep 05 Filed by: Irish Jian
Form 4 Metagenomi, Inc. For: Sep 05 Filed by: Wein Matthew
Form 10-Q Metagenomi, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.